NEW YORK, June 4 /PRNewswire-FirstCall/ -- Jesup & Lamont Inc., , a full-service boutique brokerage and investment banking firm serving retail and institutional clients, today announced that Stephen M. Dunn, Managing Director, Life Sciences Research for the LifeTech Capital Group, has joined Jesup & Lamont. William D. Dawson, Senior VP Life Sciences Research, will also accompany Mr. Dunn to Jesup & Lamont.
Mr. Dunn was previously Director of Research for Dawson James Securities, as well as Director of Life Sciences at Cabot Adams venture capital group. He has also held management positions in Business Development, Finance and Operations, having worked in over 25 countries in North America, Europe and the Far East with biomedical companies including Beckman Coulter, Coulter, Cordis (Johnson & Johnson), Telectronics (St. Jude Medical), as well as several smaller companies. With over 25 years within the global biomedical industry, Mr. Dunn has negotiated numerous intellectual property licenses, product development agreements, venture funding, M&A and joint ventures. He is a 5-star biotechnology analyst on StarMine and has appeared in both the financial and scientific media such as The Wall Street Journal, CNN, Newsweek, Forbes, Nightly Business Report, Nature Biotechnology, The Scientist, BioWorld and many other media outlets. He is also a frequent speaker and panel member for many financial, medical and venture capital events.
The LifeTech Capital Group focuses on the Life Sciences & Biotechnology sector with a concentrated focus on cutting-edge, undiscovered companies and technologies and their potential for capital growth. The group provides a broad range of products and services including institutional and retail research, expert calls, conferences, scientific panels and capital financings.
"We are extremely pleased to have someone of Stephen's caliber join Jesup as we continue to build out the products and services offered by our Capital Markets team," said James Fellus, CEO of Jesup & Lamont Securities Corp.
Stephen Dunn added, "Both Jesup's heritage and their vision of the future provide an exciting opportunity for us. Their retail and institutional distribution made them the clear choice for my team as we look to provide a unique and fresh viewpoint on the companies within the life sciences space."
To learn more about Jesup's LifeTech Capital Group and its upcoming events, please contact Mr. Stephen Dunn at 954-513-3962, or email him at sdunn@jesuplamont.com.
About Jesup & Lamont, Inc.
Established in 1877, Jesup & Lamont has an extensive history on Wall Street, with its origins encompassing such successes as providing brokerage services to Standard Oil and raising capital for the construction of Rockefeller Center. Jesup & Lamont, through wholly owned subsidiaries, offers full service broker-dealer and registered investment advisory services through its approximately 150 registered representatives in over 20 locations including offices in New York, San Francisco, Boston, Boca Raton, Chicago, Fort Lauderdale and Orlando. The Company's Jesup & Lamont Securities Corporation subsidiary also publishes proprietary research on several industries including Aerospace/Defense, Alternative Energy and Life Sciences/Healthcare and offers comprehensive investment banking services.
Forward-Looking Statement Disclaimer
This press release contains "forward looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risk, uncertainties or other factors which may cause actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Factors that might cause such a difference include, without limitation, fluctuations in the volume of transactional services provided by the Company, competition with respect to financial services commission rates, the effect of general economic and market conditions, factors affecting the securities brokerage industry as well as other risks and uncertainties detailed from time to time in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to revise or update any forward-looking statement.
Jesup & Lamont Inc.
CONTACT: Donald A. Wojnowski, President of Jesup & Lamont, Inc.,
+1-212-307-2660, DWojnowski@Jesuplamont.com
